このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Post Operative Pain and Vagal Stimulation (VAGANAL)

2026年6月29日 更新者:University Hospital, Angers

"Evolution of Postoperative Anal Pain Following Elective Proctological or Rectal Surgery Under the Effect of Transcutaneous Vagal Auricular Stimulation: a Feasibility Study - VAGANAL - Postoperative Pain and Vagal Stimulation"

Anorectal surgery is a type of surgery that can cause anal pain, particularly in the context of hemorrhoid surgery or anal fissure surgery. Generally, the period of discomfort related to the pain lasts about two weeks. There is a nerve (the vagus nerve) whose stimulation via a probe placed in the ear can reduce stress and chronic pain. Its ease of use makes it a promising tool for treating pain. Vagal auricular stimulation could be an interesting option in the management of postoperative pain of the anus and rectum. Its efficacy or feasibility in this context has never been evaluated.

The aim of this study is to evaluate the feasibility in this context and to assess the extend of pain reduction associated with perioperative nerve vagus stimulation by a medical device (Transcutaneous Electrical Nerve Stimulator (TENS ECO Plus)). It is offered to adult patients undergoing transanal anal or rectal surgery on an outpatient or inpatient basis as part of a scheduled procedure.

Patients to be included in the study are selected during the initial pre-operative consultation with the surgeon. Once the surgical indication is confirmed and the patient fulfills the study eligibility criteria, the investigator provides them with oral information about the study. The patient is also given an information sheet (written in language understandable to the patient) and a consent form.

During this initial visit, demographic data and information regarding the surgical indication are collected.

Stimulation begins two days before surgery (twice daily), followed by stimulation on the morning of surgery, one hour before arrival in the operating room. Successful completion of the stimulation, as well as any complications, are recorded in the patient diary.

On the day of surgery (day 0), data concerning the procedure and the maximum visual analogue scale (VAS) are collected in the recovery room. Analgesic consumption is also recorded.

On the evening of the procedure, stimulation is performed and adherence is recorded.

Maximum and mean VAS are collected on postoperative day 1 and then daily in the patient diary for 15 days.

Vagus nerve stimulation is performed morning and evening for 15 days. VAS scores, adherence, analgesic consumption, the date of the first bowel movement and its painfulness, as well as any complications related to the stimulation are noted in the patient diary. On day 3 (+/- 2 days) after the procedure, and at the end of the 15-day postoperative period, the patient will be contacted by phone or text message by the investigator team to remind them to complete the notebook.

On day 30 (+/- 5 days), the patient returns for a follow-up visit. The patient diary and equipment are collected. Complications are recorded, as well as quality of life during the postoperative month (SF-36 form).

For patients, the expected benefits are significant, as postoperative quality of life is expected to improve through reduced pain. Furthermore, decreasing the use of step II and III analgesics should shorten the recovery period and promote better overall recovery.

調査の概要

研究の種類

介入

入学 (推定)

50

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

    • Maine et Loire
      • Angers、Maine et Loire、フランス、49933
        • Angers Hospital
        • コンタクト:
        • 主任研究者:
          • sarfati Marine, MD

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Adult patient
  • Underwent anal or rectal surgery via the transanal route
  • Managed on an outpatient basis or in conventional hospitalization
  • Having signed a consent to participate in the study

Exclusion Criteria:

  • Patient operated on as an emergency
  • Rectal surgery via abdominal approach or requiring an abdominal approach during the procedure
  • Known epileptic patient
  • Patient with a pacemaker
  • Patient refusing to participate in the study
  • Pregnant, breastfeeding, or laboring woman
  • Patient not affiliated with a social security scheme
  • Person deprived of liberty by judicial or administrative decision
  • Person subject to compulsory psychiatric care - Any contraindication mentioned in the instructions for use of the medical device under investigation

Exclusion Criteria:

  • Unscheduled conversion from the transanal route to the abdominal route during surgery

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:active nerve vagus stimulator
assessment of rectal post operative pain with active nerve vagus stimulation
active vagus nerve stimulation
偽コンパレータ:control arm
assessment of rectal post operative pain without active nerve vagus stimulation
no active vagus nerve stimulation

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
consumption of analgesic
時間枠:From Day 0 to Day 15
the post-operative consumption of analgesic is evaluated in the recovery room (day 0) and then every day for 15 days. Post-operative consumption is assessed in patients treated with auricular vagus active nerve stimulation and in patients with a inactive device.
From Day 0 to Day 15
Change of pain after perioperative auricular vagus nerve stimulation
時間枠:day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8, day 9, day 10, day 11, day 12, day 13, day 14, day 15
The intensity of anal pain is measured by the Visual Analog Scale (VAS) from 0 to 10 in the recovery room and then every day for 15 days. This VAS is assessed in patients treated with auricular vagus active nerve stimulation and in patients with a inactive device. The higher score means a worse outcome.
day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8, day 9, day 10, day 11, day 12, day 13, day 14, day 15

二次結果の測定

結果測定
メジャーの説明
時間枠
adverse events
時間枠:day 30
adverse events occuring during the first month after surgery and specifically related to the surgery are collected by the investigator for the two groups of patients
day 30
acceptability of perioperative auricular vagus nerve stimulation by the patient
時間枠:day 15
The acceptability of treatment by perioperative auricular vagal stimulation is assessed at day 15 by asked question to the two groups of patients. The question is "do you think that the treatment with vagus nerve stimulation is non-binding?"
day 15
Delay in gastrointestinal motility recovery (passage of stool) and post-defecatory pain
時間枠:from day 0 to day 30
The gastrointestinal transit recovery after surgery is recorded in the patients treated with active device and in patients treated with inactive device. Post defecatory pain more than 30 min is also reported in the patients with active and with inactive device.
from day 0 to day 30
Quality of life of patients after surgery
時間枠:Day 30
quality of life by health survey SF 36 (the 36-item Short Form Health Survey) is assessed at the day 30 after surgery in the two groups of patients (active device and no active device). SF 36 covers eight health domains: physical functioning (10 items), bodily pain (2 items), role limitations due to physical health problems (4 items), role limitations due to personal or emotional problems (4 items), emotional well-being (5 items), social functioning (2 items), energy/fatigue (4 items), and general health perceptions (5 items). Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.
Day 30

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年11月9日

一次修了 (推定)

2027年11月9日

研究の完了 (推定)

2028年1月9日

試験登録日

最初に提出

2026年6月15日

QC基準を満たした最初の提出物

2026年6月15日

最初の投稿 (実際)

2026年6月22日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月1日

QC基準を満たした最後の更新が送信されました

2026年6月29日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 49RC25-0293
  • 2026-A01004-47 (その他の識別子:ANSM)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する